The pharmacoeconomics of peri-operative beta-blocker therapy.
about
Acute peri-operative beta blockade in intermediate-risk patients.Minimizing cardiac risk in perioperative practice - interdisciplinary pharmacological approaches.Use of number needed to treat in cost-effectiveness analyses.Preoperative staging of lung cancer with PET/CT: cost-effectiveness evaluation alongside a randomized controlled trial.
P2860
The pharmacoeconomics of peri-operative beta-blocker therapy.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
The pharmacoeconomics of peri-operative beta-blocker therapy.
@ast
The pharmacoeconomics of peri-operative beta-blocker therapy.
@en
type
label
The pharmacoeconomics of peri-operative beta-blocker therapy.
@ast
The pharmacoeconomics of peri-operative beta-blocker therapy.
@en
prefLabel
The pharmacoeconomics of peri-operative beta-blocker therapy.
@ast
The pharmacoeconomics of peri-operative beta-blocker therapy.
@en
P2860
P1433
P1476
The pharmacoeconomics of peri-operative beta-blocker therapy.
@en
P2093
P2860
P356
10.1111/J.1365-2044.2005.04401.X
P407
P50
P577
2006-01-01T00:00:00Z